InvestAcure, PBC ^Company

InvestAcure is a finance company building an investment platform to enable individuals who share a ‘Common Need’ to see progress in developing a cure for Alzheimer’s, to automatically round up purchases and invest the change in a portfolio of companies working on effective treatments. Its 3-year plan is to reach 1.7+ million users, investing $1 billion per annum to develop scientific innovations from basic research into lifesaving therapeutics. The company was founded in 2017 and based in New York. The problem we are solving: Alzheimer’s is the only top 10 cause of death with no treatment to cure or slow the disease - it’s 100% fatal! It is also the most expensive disease in the US, costing $277 billion in 2018 - as much as $1.1 trillion by 2050. Alzheimer’s must be cured! Yet, investment risk has led most major pharmaceuticals to cut back on Alzheimer’s R&D as unprofitable, while smaller scientist-led companies struggle to develop scientific discoveries into life-saving drugs. Does it make sense for millions to die helplessly, just because no one can reliably make a profit developing a cure? Our solution: JUST IMAGINE - what if drug companies were owned by millions of investors motivated by their ‘Common Need’ to see Alzheimer’s cured, with each investing just the spare change they don’t depend on for future financial needs - there would be billions in new investment to develop and test new drugs and cure would become the #1 priority above profit. To realize this vision, InvestAcure is building a spare change investment platform to help you invest in companies working on a cure for Alzheimer’s. Just spare change: Your day-to-day transactions are rounded up to the nearest dollar & the spare change is deposited in your InvestAcure investment account. Invest: With the guidance of leading scientists, your spare change is invested in a portfolio of companies working on developing innovative Alzheimer’s drugs & diagnostics. Ownership + Impact: YOU own stock. YOU help advance progress to a cure. YOU have a fair share in any profit. We coined this new investment model, Common Need Investment (CNI), which refers to Investments made in a company based on its pursuit of essential work valued by the investors above financial profit or loss. If just 1.5% of the 70 million adults in the U.S. who have a relative with Alzheimer's become spare change investors, that would mean $600 million in annual investment - $3 billion over 5 years. Management Team Includes: -